sever
acut
respiratori
syndrom
sar
first
recogn
global
outbreak
sever
pneumonia
first
occur
late
guangdong
provinc
china
erupt
februari
case
two
dozen
countri
asia
europ
north
america
south
america
diseas
caus
influenzalik
ill
fever
cough
dyspnea
headach
sever
case
caus
human
death
persontoperson
transmiss
combin
intern
travel
infect
person
acceler
worldwid
spread
ill
time
outbreak
contain
probabl
case
result
death
report
outbreak
global
network
laboratori
establish
world
health
organ
identifi
causal
agent
earli
investig
clinic
patholog
laboratori
studi
focus
previous
known
agent
respiratori
ill
subsequ
howev
previous
unknown
viru
isol
oropharynx
sar
patient
identifi
ultrastructur
characterist
belong
famili
coronavirida
find
shift
focu
investig
toward
verif
role
play
newli
recogn
coronaviru
vast
array
laboratori
approach
util
investig
includ
patholog
serolog
molecular
assay
within
week
infect
nonhuman
primat
achiev
thu
establish
anim
model
sar
coronaviru
sarscov
chapter
present
morpholog
characterist
sarscov
grown
tissu
cultur
histopatholog
chang
electron
microscop
find
cellular
local
viru
tissu
human
patient
experiment
infect
anim
addit
pathophysiolog
newli
emerg
viru
discuss
sever
report
describ
diffus
alveolar
damag
variou
level
progress
sever
main
histopatholog
find
sar
patient
lung
typic
show
chang
prolif
phase
diffus
alveolar
damag
hyalinemembran
format
desquam
epitheli
cell
fibrin
deposit
alveolar
space
hyperplasia
type
pneumocyt
fig
b
increas
mononuclear
infiltr
interstitium
seen
case
find
identifi
patient
includ
focal
intraalveolar
hemorrhag
necrot
inflammatori
debri
small
airway
organ
pneumonia
addit
multinucl
syncyti
cell
seen
intraalveolar
space
patient
die
day
onset
ill
fig
cell
contain
abund
vacuol
cytoplasm
cleav
convolut
nuclei
obviou
intranuclear
intracytoplasm
viral
inclus
identifi
ultrastructur
characterist
sarscov
describ
recent
report
matur
similar
featur
previous
describ
coronavirus
virion
form
align
helic
nucleocapsid
along
membran
endoplasm
reticulum
golgi
complex
bud
lumina
cisterna
fig
vesicl
becom
fill
virion
progress
cell
surfac
releas
viru
particl
larg
number
particl
remain
adher
plasma
membran
cell
surfac
fig
cytoplasm
structur
associ
infect
includ
doublemembran
vesicl
propos
replic
complex
viru
nucleocapsid
inclus
fig
immunogold
electron
microscopi
use
hyperimmun
mous
ascit
fluid
use
confirm
viral
natur
particl
inclus
fig
infect
vero
cell
sarscov
produc
characterist
syncyti
cell
similar
sometim
observ
lung
patient
die
light
microscopi
abund
viral
antigen
detect
cytoplasm
cell
grown
tissu
cultur
fig
situ
hybrid
ish
immunohistochem
ihc
studi
tissu
sar
patient
demonstr
coronaviru
infect
upper
airway
bronchiolar
epithelium
infect
ciliat
columnar
epitheli
cell
seen
focal
line
epithelium
trachea
larger
bronchi
fig
mani
infect
cell
slough
epithelium
observ
use
ish
within
bronchial
lumen
fig
similarli
ultrastructur
examin
bronchiolar
lavag
sar
patient
show
numer
coronavirusinfect
cell
fig
abund
viral
antigen
also
found
distribut
focal
parenchyma
lung
patient
seen
predominantli
cytoplasm
pneumocyt
fig
occasion
macrophag
fig
associ
intraalveolar
necrot
debri
fibrin
fig
doublestain
studi
reveal
sarscovinfect
cell
type
pneumocyt
colabel
surfact
occasion
macrophag
colabel
doublestain
studi
also
detect
viral
nucleic
acid
distribut
similar
seen
ihc
studi
mainli
pneumocyt
macrophag
electron
microscop
examin
lung
tissu
select
area
abund
ihc
stain
show
numer
coronaviru
particl
nucleocapsid
inclus
fig
virion
seen
cytoplasm
vesicl
along
cell
membran
pneumocyt
phagosom
macrophag
associ
fibrin
alveolar
space
coronaviru
particl
may
confus
morpho
logic
nonvir
cellular
compon
definit
ultrastructur
identif
achiev
use
immunogold
label
electron
microscopi
iem
fig
primari
histopatholog
lesion
seen
lung
patient
die
sar
somewhat
nonspecif
also
seen
acut
lung
injuri
case
caus
infecti
agent
trauma
drug
toxic
chemic
multinucl
syncyti
cell
similar
seen
sar
patient
also
found
number
viru
infect
includ
measl
parainfluenzavirus
respiratori
syncyti
viru
nipah
viru
infect
earli
studi
four
human
sar
patient
abl
demonstr
viral
antigen
lung
ihc
like
explan
tissu
sampl
studi
patient
clinic
cours
averag
week
mani
viru
infect
viral
antigen
nucleic
acid
clear
within
week
diseas
onset
host
immun
respons
also
possibl
pulmonari
damag
associ
sar
caus
directli
viru
repres
secondari
effect
cytokin
factor
induc
viru
infect
influenza
viru
infect
viral
antigen
seen
predominantli
respiratori
epitheli
cell
larg
airway
rare
identifi
pulmonari
parenchyma
despit
concomit
occasion
sever
interstiti
pneumon
recent
report
shieh
et
al
chong
et
al
tempor
relationship
durat
ill
clearanc
sarscov
human
lung
tissu
examin
viral
antigen
nucleic
acid
detect
pulmonari
tissu
patient
die
earli
diseas
develop
specif
ihc
ish
iem
assay
identifi
sarscov
formalinfix
paraffinembed
sampl
also
allow
assess
cellular
tropism
sarscov
infect
human
lung
tissu
local
sarscov
lung
occur
mainli
cytoplasm
pneumocyt
primarili
type
occasion
alveolar
macrophag
type
pneumocyt
known
secret
pulmonari
surfact
result
reduc
surfac
tension
preserv
integr
alveolar
space
cell
also
play
import
role
tissu
restitut
follow
lung
damag
moreov
mount
evid
support
contribut
develop
acut
inflammatori
lung
injuri
follow
exposur
biolog
chemic
agent
addit
studi
need
defin
role
type
pneumocyt
alveolar
macrophag
sarscov
infect
sever
morbid
mortal
associ
sar
make
imper
effect
mean
prevent
treat
diseas
develop
evalu
especi
sinc
known
whether
viru
reappear
exhibit
season
pattern
circul
like
respiratori
viru
pathogen
whether
independ
reintroduc
human
popul
cynomolgu
macaqu
report
develop
patholog
find
pneumonia
propos
anim
model
sar
haagman
et
al
show
extens
sarscov
antigen
express
experiment
infect
cynomolgu
macaqu
day
infect
antigen
mainli
alveolar
line
epitheli
cell
morpholog
characterist
type
pneumocyt
indic
type
pneumocyt
primari
target
sarscov
infect
earli
diseas
type
pneumocyt
normal
repres
alveolar
epitheli
cell
volum
easili
damag
pulmonari
infect
type
injuri
recent
studi
nonhuman
primat
evid
found
infect
mainli
type
pneumocyt
addit
type
pneumocyt
macrophag
small
anim
model
rodent
would
use
evalu
vaccin
immunotherapi
antivir
drug
recent
mous
identifi
anim
model
purpos
studi
microscop
examin
trachea
bronchu
lung
thymu
heart
day
infect
reveal
mild
focal
peribronchiolar
mononuclear
inflammatori
infiltr
fig
signific
histopatholog
chang
organ
viral
antigen
nucleic
acid
focal
distribut
bronchiolar
epitheli
cell
fig
virion
found
area
ultrastructur
analysi
fig
data
indic
sarscov
replic
high
enough
titer
mice
abl
evalu
vaccin
antivir
model
mous
small
anim
model
might
also
use
test
abil
viru
replic
caus
diseas
thu
facilit
identif
hostimmun
mechan
contribut
resolut
sarscov
infect
emerg
sarscov
pose
major
threat
global
health
specif
etiolog
diagnosi
particularli
import
outbreak
impact
hospit
infect
control
public
health
measur
discoveri
new
viru
occur
broadbas
multidisciplinari
effort
clinic
epidemiolog
laboratori
investig
speak
power
global
collabor
effort
address
everpres
threat
emerg
infecti
diseas
identif
novel
coronaviru
reli
classic
tissuecultur
isol
amplifi
pathogen
electronmicroscop
studi
identifi
type
viru
molecular
studi
confirm
ident
viru
character
uniqu
natur
help
link
diseas
discoveri
previous
unknown
viru
member
famili
coronavirida
underscor
import
versatil
laboratori
techniqu
viru
isol
electron
microscopi
identifi
etiolog
pathogen
previou
outbreak
investig
electron
microscopi
prove
rapid
techniqu
requir
specif
reagent
prior
knowledg
particular
agent
could
never
theless
categor
pathogen
basi
appear
morphogenesi
techniqu
combin
tradit
method
includ
viru
isol
suckl
mice
cell
cultur
histopatholog
examin
serolog
analysi
molecular
techniqu
polymeras
chain
reaction
pcr
reversetranscript
pcr
realtim
pcr
also
use
invalu
character
discoveri
novel
viru
summari
sinc
clinic
featur
sarscov
infect
similar
mani
respiratori
infect
definit
diagnosi
made
laboratori
confirm
tradit
patholog
method
associ
contemporari
molecular
patholog
method
help
enhanc
patholog
diagnosi
understand
pathogenesi
sarscov
infect
